 |
IQVIA¢â(formerly QuintilesIMS)  |
[IQVIA]We¡¯re Now Hiring - Open Positions
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
 |
|
 |
IQVIA¢â  |
IQVIA CRA¸ðÁý°ø°í
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
 |
|
 |
IQVIA  |
CRA¸ðÁý°ø°í_IQVIA (urgent position) new
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.22 |
|
|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ)  |
[±Û·Î¹ú Á¦¾à»ç] Senior Product Manager, Rare Disease ä
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
09.21 |
|
|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ)  |
[±Û·Î¹ú Á¦¾à»ç] Clinical Quality and Training Lead ä¿ë
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
5³â¡è |
ä¿ë½Ã |
09.20 |
|
|
(ÁÖ)Á¦À̾¾¹ÙÀÌ¿À |
Revvity Cisbio ÇмúÁö¿ø&±â¼ú¿µ¾÷¸¶ÄÉÆÃ Ã¤¿ë
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÇÏ¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.15 |
|
|
(ÁÖ)Á¦À̾¾¹ÙÀÌ¿À |
Standard Biotools ÇмúÁö¿ø&±â¼ú¿µ¾÷¸¶ÄÉÆÃ Ã¤¿ë
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.15 |
|
|
(ÁÖ)Á¦À̾¾¹ÙÀÌ¿À |
ONTÇмúÁö¿ø&±â¼ú¿µ¾÷¸¶ÄÉÆÃ Ã¤¿ë
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.15 |
|
|
(ÁÖ)¿¡ÇÁ¾Øµð³Ý |
º»»ç °Ç°±â´É½Äǰ ¿µ¾÷»ç¿ø Á¤±Ô ä¿ë
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°Ç°º¸Á¶½Äǰ/ÈÀåǰ¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.15 |
|
|
(ÁÖ)¿À·¡¿Â¶óÀÌÇÁ»çÀ̾𽺠|
[¸ÞµðÄà ¿¡½ºÅׯ½] ÇØ¿Ü¿µ¾÷ °æ·Â ä¿ë
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
1³â¡è |
ä¿ë½Ã |
09.13 |
|
|
¿¡Áö¾Ó |
[¸ÞµðÄà ¿¡½ºÅׯ½] RA °æ·Â ä¿ë
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
09.12 |
|
|
¹Ì·¡ÄÄÆÛ´Ï |
ÀÇ·á±â±â ÀÓ»ó ÄÁ¼³ÅÏÆ® ä¿ë
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
10.12 |
09.12 |
|
|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ)  |
[±Û·Î¹ú Á¦¾à»ç] Clinical Research Associate ä¿ë (Á¤±ÔÁ÷
¼¿ï ¼ÛÆÄ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
09.11 |
|
|
(ÁÖ)Á¦À̾¾¹ÙÀÌ¿À |
ÇмúÁö¿ø ä¿ë (»ý¸í°øÇÐ/¹ÙÀÌ¿ÀÀü°ø)
¼¿ï ¼ÛÆÄ±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
°æ·Â¹«°ü |
10.10 |
09.11 |
|
|
Çѱ¹¹ÙÀÌ¿ÀÆÊ(ÁÖ) |
°Ç°±â´É½Äǰ Á¦Ç°°³¹ß / ¿µ¾÷Áö¿ø Á¤±ÔÁ÷ Àüȯ ÀÎÅÏ»ç¿ø ä
¼¿ï ¼ÛÆÄ±¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.05 |
|